APA Alıntı

Gonzales, A. J., Bowman, J. W., Fici, G. J., Zhang, M., Mann, D. W., & Mitton-Fry, M. (2014). Oclacitinib (APOQUEL®) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy. J Vet Pharmacol Ther.

Chicago Stili Alıntı

Gonzales, A J., J W. Bowman, G J. Fici, M. Zhang, D W. Mann, ve M. Mitton-Fry. "Oclacitinib (APOQUEL®) Is a Novel Janus Kinase Inhibitor With Activity against Cytokines Involved in Allergy." J Vet Pharmacol Ther 2014.

MLA Alıntı

Gonzales, A J., et al. "Oclacitinib (APOQUEL®) Is a Novel Janus Kinase Inhibitor With Activity against Cytokines Involved in Allergy." J Vet Pharmacol Ther 2014.